Publication | Open Access

The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii

Antimicrobial SusceptibilityCarbapenem-resistant Acinetobacter BaumanniiHigher SurvivalAntibacterial AgentAntimicrobial ChemotherapyInfection ControlMedicineClinical MicrobiologyHigh-dose ColistinAntimicrobial Resistance